Related Experiment Videos
Systemic glucocorticoids in severe exacerbations of COPD
A Sayiner1, Z A Aytemur, M Cirit
1Department of Chest Diseases, Ege University Medical School, Izmir, Turkey. asayiner@med.ege.edu.tr
Chest
|March 13, 2001
Summary
A 10-day course of methylprednisolone (MP) is more effective for severe COPD exacerbations than a 3-day course. Longer steroid treatment improves outcomes but does not reduce future exacerbation rates.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Severe chronic obstructive pulmonary disease (COPD) exacerbations often require hospitalization.
- Corticosteroids are a cornerstone of COPD exacerbation management.
- Optimal duration of corticosteroid therapy remains debated.
Purpose of the Study:
- To compare the efficacy of 3-day versus 10-day methylprednisolone (MP) courses.
- To evaluate treatment outcomes in severe COPD exacerbations requiring respiratory support.
Main Methods:
- Prospective, randomized, single-blind study at a tertiary-care center.
- 36 patients with severe COPD exacerbations were randomized.
- Group 1 received 3-day MP; Group 2 received 10-day MP with tapering.
Main Results:
- Both groups improved PaO2 and FEV1, with greater improvement in Group 2 (p=0.012, p=0.019).
- Group 2 showed significant FVC increase (p=0.003) and better dyspnea relief.
- No significant difference in pH, PaCO2, symptom scores, or future exacerbation rates.
Conclusions:
- A 10-day methylprednisolone course is superior to a 3-day course for severe COPD exacerbations.
- Extended steroid treatment improves lung function and reduces dyspnea.
- Steroid duration does not impact subsequent exacerbation frequency.